These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2872103)

  • 1. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.
    Zhang JM; Cowell JL; Steven AC; Manclark CR
    Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of fimbriae isolated from Bordetella pertussis.
    Zhang JM; Cowell JL; Steven AC; Carter PH; McGrath PP; Manclark CR
    Infect Immun; 1985 May; 48(2):422-7. PubMed ID: 2859248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release and purification of fimbriae from Bordetella pertussis.
    Irons LI; Ashworth LA; Robinson A
    Dev Biol Stand; 1985; 61():153-63. PubMed ID: 2872101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae.
    Cowell JL; Zhang JM; Urisu A; Suzuki A; Steven AC; Liu T; Liu TY; Manclark CR
    Infect Immun; 1987 Apr; 55(4):916-22. PubMed ID: 2881893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
    Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against intranasal infection of mice with Bordetella pertussis.
    Robinson A; Ashworth LA; Baskerville A; Irons LI
    Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential immunogens in human pertussis: the role of fimbriae.
    Preston NW
    Dev Biol Stand; 1985; 61():137-41. PubMed ID: 2872099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agglutinogens and fimbriae of Bordetella pertussis.
    Ashworth LA; Robinson A; Funnell S; Gorringe AR; Irons LI; Seabrook RN
    Tokai J Exp Clin Med; 1988; 13 Suppl():203-10. PubMed ID: 2908520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of the immune potency of lymphocyte-promoting factor (LPF) and filamentous hemagglutinin (FHA) molecules by intranasal challenge in mice].
    Ozcengiz E; Günalp A
    Mikrobiyol Bul; 1991 Apr; 25(2):131-7. PubMed ID: 1745145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis.
    Ashworth LA; Irons LI; Dowsett AB
    Infect Immun; 1982 Sep; 37(3):1278-81. PubMed ID: 6127315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The location of surface antigens of Bordetella pertussis by immuno-electron microscopy.
    Ashworth LA; Dowsett AB; Irons LI; Robinson A
    Dev Biol Stand; 1985; 61():143-51. PubMed ID: 2872100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serospecific protection of mice against intranasal infection with Bordetella pertussis.
    Robinson A; Gorringe AR; Funnell SG; Fernandez M
    Vaccine; 1989 Aug; 7(4):321-4. PubMed ID: 2573215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Bordetella pertussis agglutinogen 2 and fimbriae.
    Carter EJ; Preston NW
    J Med Microbiol; 1984 Aug; 18(1):87-94. PubMed ID: 6146723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rapid purification of Bordetella pertussis fimbria 2, 3 proteins and their immunogenicities].
    Atakan Ablay P; Ozcengiz E
    Mikrobiyol Bul; 2007 Jan; 41(1):11-20. PubMed ID: 17427548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular fractions for immunizing against pertussis.
    Parker CD; Field LH; Berry LJ; Manclark C
    Dev Biol Stand; 1978; 41():23-9. PubMed ID: 223910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional properties of a 69-kilodalton outer membrane protein of Bordetella pertussis.
    Brennan MJ; Li ZM; Shahin RD; Burns DL; Nguyen NY; Liu TY; Gray MC; Hewlett EL; Manclark CR
    Tokai J Exp Clin Med; 1988; 13 Suppl():211-5. PubMed ID: 2908522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
    Robinson A; Irons LI
    Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.
    Willems RJ; Kamerbeek J; Geuijen CA; Top J; Gielen H; Gaastra W; Mooi FR
    Vaccine; 1998 Feb; 16(4):410-6. PubMed ID: 9607064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.